The global vascular graft market is growing at 6.6% CAGR owing to the rising prevalence of cardiovascular diseases and arotic aneurysms along with chronic kidney disease, rising geriatric population, sedentary lifestyle, unhealthy diet, the rising prominence of smoking and alcohol abuse will fuel the growth of the global vascular graft market. Moreover, the rising demand for hemodialysis, an increasing number of Minimally Invasive Direct Artery Bypass (MIDCAB) procedures, and the increasing prevalence of diabetes and end-stage renal disorders will further augment the growth of the global vascular graft market. Nevertheless, the increasing purchasing power parity, supportive reimbursement policies of vascular surgeries, and rising demand for technologically developed products will create promising opportunities for the global vascular graft market during the forecast period 2021-2027.

The COVID-19 pandemic has resulted in the decline in the sale of vascular graft products in 2020 owing to the postponement of elective surgeries and non-invasive procedures as they are not critical or lifesaving procedures and the entire focus was on COVID-19 patients. However, the introduction of new solutions by industry players and adopting strategies like M&A, collaborations, the product launch will provide a competitive edge in delivering value-based core post-COVID-19 crisis.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/vascular-graft-market/request-sample

Based on raw material, the polyester graft dominates the market in 2020 owing to its ease in availability, long lifespan, high patency, porousness, high tensile strength, and are durable. Moreover, the mounting cardiovascular diseases and neurovascular disorders is anticipated to have significant growth in the polyester graft segment.

Based on indication, the endovascular aneurysm repair contributes to the largest market share owing to the rising surgical procedures adopting endovascular aneurysm over open repair procedures, growing prominence of minimally invasive surgical procedures, and rising geriatric population.

Asia-Pacific is anticipated to have the fastest growth in the vascular graft market owing to the increased prominence of CKD, reforms in healthcare sector, investments and initiatives by the government, and robust growth in the geriatric population.

North America is anticipated to contribute the largest share in the vascular graft market owing to enhanced healthcare facilities and rising awareness about cardiovascular treatment, technological development such as innovation of specific tissue-engineered products leading to the growth of biomaterial vascular grafts, precise diagnostic procedures via biometric tools will fuel the growth in the region.

In 2021, Cook Medical Inc. has received FDA approval for Zenith's fenestrated endovascular graft. It offers effective diagnosis for life-threatening or irreversibly devastating diseases or conditions, resulting in adding value to its existing portfolio and generating high revenue from its sales.

The prominent players in the vascular graft industry include Medtronic Plc, Terumo Corporation, Maquet, C. R. Bard, B. Braun Melsungen AG, Lemaitre Vascular, Cardinal Health, Endologix, Cook Medical Inc., and W.L. Gore & Associates Inc.

Source: VynZ Research